The first report of uncontrollable subchorionic and retroplacental haemorrhage inducing preterm labour in complete PAI-1 deficiency in a human

Thrombosis Research

Volumn 129, Issue 4, 2012, Pages

  Iwaki, Takayuki ^a   Nagahashi, Kotomi ^a   Kobayashi, Takao ^b   Umemura, Kazuo ^a   Terao, Toshihiko ^a   Kanayama, Naohiro ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HAMAMATSU MEDICAL CENTER   (Japan)

Author keywords

coagulation factor; F; FFP; Fresh frozen plasma; PAI 1; Plasminogen activator inhibitor 1; serine protease inhibitor; SERPIN

Indexed keywords

D DIMER; FIBRINOGEN; FRESH FROZEN PLASMA; PLASMINOGEN ACTIVATOR INHIBITOR 1;

AFIBRINOGENEMIA; BLEEDING; BLOOD CLOTTING FACTOR 13 DEFICIENCY; CANCER PATIENT; CANCER PROGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; ECHOGRAPHY; FETUS GROWTH; FETUS HEART RATE; FIBRINOGEN BLOOD LEVEL; GENITAL BLEEDING; GESTATIONAL AGE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; IN VIVO STUDY; LETTER; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; PROTHROMBIN TIME; SOLUTIO PLACENTAE; SPONTANEOUS ABORTION; SUBCHORIONIC HEMORRHAGE; UTERUS CONTRACTION;

ADULT; BLOOD COAGULATION DISORDERS; FEMALE; HUMANS; MIDDLE AGED; OBSTETRIC LABOR, PREMATURE; PLASMINOGEN ACTIVATOR INHIBITOR 1; POSTPARTUM HEMORRHAGE; PREGNANCY;

EID: 84858335416     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.10.008     Document Type: Letter

References (18)

1. D.J. Loskutoff, M. Sawdey, and J. Mimuro Type 1 plasminogen activator inhibitor Prog Hemost Thromb 9 1989 87 115
2. M.E. Meltzer, C.J. Doggen, P.G. de Groot, F.R. Rosendaal, and T. Lisman The impact of the fibrinolytic system on the risk of venous and arterial thrombosis Semin Thromb Hemost 35 2009 468 477
3. B.R. Binder, and J. Mihaly The plasminogen activator inhibitor "paradox" in cancer Immunol Lett 118 2008 116 124
4. T. Iwaki, A. Tanaka, Y. Miyawaki, A. Suzuki, T. Kobayashi, and J. Takamatsu Life-threatening hemorrhage and prolonged wound healing are remarkable phenotypes manifested by complete plasminogen activator inhibitor-1 deficiency in humans J Thromb Haemost 9 2011 1200 1206
5. W.P. Fay, A.D. Shapiro, J.L. Shih, R.R. Schleef, and D. Ginsburg Brief report: complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation N Engl J Med 327 1992 1729 1733
6. T. Iwaki, and F.J. Castellino Maternal fibrinogen is necessary for embryonic development Curr Drug Targets 6 2005 535 539
7. T. Asahina, T. Kobayashi, K. Takeuchi, and N. Kanayama Congenital blood coagulation factor XIII deficiency and successful deliveries: a review of the literature Obstet Gynecol Surv 62 2007 255 260
8. A. Ichinose, T. Asahina, and T. Kobayashi Congenital blood coagulation factor XIII deficiency and perinatal management Curr Drug Targets 6 2005 541 549
9. T. Kobayashi, T. Terao, T. Kojima, J. Takamatsu, T. Kamiya, and H. Saito Congenital factor XIII deficiency with treatment of factor XIII concentrate and normal vaginal delivery Gynecol Obstet Invest 29 1990 235 238
10. T. Kobayashi, N. Kanayama, N. Tokunaga, T. Asahina, and T. Terao Prenatal and peripartum management of congenital afibrinogenaemia Br J Haematol 109 2000 364 366
11. T.T. Suh, K. Holmback, N.J. Jensen, C.C. Daugherty, K. Small, and D.I. Simon Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice Genes Dev 9 1995 2020 2033
12. V.A. Ploplis, J. Wilberding, L. McLennan, Z. Liang, I. Cornelissen, and M.E. DeFord A total fibrinogen deficiency is compatible with the development of pulmonary fibrosis in mice Am J Pathol 157 2000 703 708
13. S. Koseki-Kuno, M. Yamakawa, G. Dickneite, and A. Ichinose Factor XIII A subunit-deficient mice developed severe uterine bleeding events and subsequent spontaneous miscarriages Blood 102 2003 4410 4412
14. T. Iwaki, M.J. Sandoval-Cooper, M. Paiva, T. Kobayashi, V.A. Ploplis, and F.J. Castellino Fibrinogen stabilizes placental-maternal attachment during embryonic development in the mouse Am J Pathol 160 2002 1021 1034
15. R. Mehta, and A.D. Shapiro Plasminogen activator inhibitor type 1 deficiency Haemophilia 14 2008 1255 1260
16. P. Carmeliet, J.M. Stassen, L. Schoonjans, B. Ream, J.J. van den Oord, and M. De Mol Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis J Clin Invest 92 1993 2756 2760
17. H.J. Nielsen, C. Reimert, A.N. Pedersen, E. Dybkjoer, N. Brunner, and B. Alsbjorn Leucocyte-derived bioactive substances in fresh frozen plasma Br J Anaesth 78 1997 548 552
18. D.E. Vaughan, P.J. Declerck, E. Van Houtte, M. De Mol, and D. Collen Studies of recombinant plasminogen activator inhibitor-1 in rabbits. Pharmacokinetics and evidence for reactivation of latent plasminogen activator inhibitor-1 in vivo Circ Res 67 1990 1281 1286